Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2003
10/16/2003US20030194793 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194792 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194791 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194790 DNA sequences coding for ester-group-cleaving enzymes
10/16/2003US20030194786 Used for genetic engineering; involving hydrogen bonds
10/16/2003US20030194785 Making an erythromycin derivative of given formula by fermenting an organism capable of producing erythromycin in the presence of a carboxylic acid of given formula
10/16/2003US20030194784 Recombinant polyhydroxyalkanoate synthases are derived from multifunctional fatty acid synthases or polyketide synthases that generate hydroxyacyl acids capable of forming polylactones via polyhydroxyalkanoate synthase
10/16/2003US20030194782 Methods for recombinant peptide production
10/16/2003US20030194779 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194778 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194777 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194776 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194775 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194774 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194773 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194772 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194771 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194770 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194769 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194768 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194767 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194766 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194765 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194763 End selection in directed evolution
10/16/2003US20030194761 Novel nucleic acid sequences encoding human fibroblast growth factor-like polypeptides
10/16/2003US20030194760 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194749 Wortmannin derivatives as probes of cellular proteins and processes
10/16/2003US20030194743 Binding polypeptides for B lymphocyte stimulator protein (BLyS)
10/16/2003US20030194740 System and method for nucleic acid sequencing by polymerase synthesis
10/16/2003US20030194739 Using cancer specific genes
10/16/2003US20030194738 Antisense oligonucletoide to c-Fos; used to control cell proliferation and treat tumors; oligonucleotides with modified linkages, nucleobases, and sugar groups; pharmaceutical mixture with chemotherapeutic agents
10/16/2003US20030194736 Methods and compositions for DNA manipulation
10/16/2003US20030194733 Cancer diagnostic panel
10/16/2003US20030194732 For treating neoplastic diseases by testing responsiveness to interferons
10/16/2003US20030194729 Conantokins
10/16/2003US20030194727 Screening nucleic acids that encode different artificial, chimeric proteins to identify a chimeric protein that alters a phenotypic trait of a cell or organism
10/16/2003US20030194726 Thermus oshimai nucleic acid polymerases
10/16/2003US20030194725 Creating a database of related protein/nucleic acid sequences with annotations of the potential disease associations of the sequences; testing the potential disease associations by means of a biological assay and validating the disease association
10/16/2003US20030194724 Evaluation of sequence information to characterize putative heterozygous indel mutations to identify mixed-base presence resulting from allelic differences; used to resolve single nucleotide polymorphisms, insertions, deletions
10/16/2003US20030194723 Relates to hybridization assay probes, capture probes, amplification primers, nucleic acid compositions, methods and kits useful for determining the presence of Mycoplasma pneumoniae and/or Mycoplasma genitalium
10/16/2003US20030194721 Differentially expressed when foam cells are treated with oxidized low-density lipoprotein and LPS as associated with atherosclerosis
10/16/2003US20030194720 Human ion channels
10/16/2003US20030194716 Used in combinatory chemistry, in-situ synthesis, parallel synthesis, solid phase synthesis or the production of arrays
10/16/2003US20030194714 Production of achromosomal and anucleate cells useful for applications such as diagnositic and therapeutic uses, as well as research tools and agents for drug discovery
10/16/2003US20030194710 Method for making a molecularly smooth surface
10/16/2003US20030194709 A genetic analysis chip having a hydrophobic zone, bounding a hydrophilic zone in which a genetic sample can be analyzed
10/16/2003US20030194707 Contacting a composition comprising nucleic acid with an effective amount of glycogen to facilitate precipitation of nucleic acid and ethanol in the presence of a carboxylated paramagnetic bead
10/16/2003US20030194702 Sequences for use in diagnosis and treatment of carcinomas, used in screening methods
10/16/2003US20030194696 High efficient method of introducing DNA into poxvirus, producing libraries interest based on cell nonviability or screening or selection methods
10/16/2003US20030194694 Pure recombinant influenza virus comprising a mutant ion channel protein which lacks or has reduced activity relative to the wild-type
10/16/2003US20030194414 Replikin peptides and antibodies therefore
10/16/2003US20030194408 Antibody which specifically binds to at least two variants of an epitope of an HIV-1 Tat protein
10/16/2003US20030194406 P-cadherin as a target for anti-cancer therapy
10/16/2003US20030194404 Gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules; especially for treating asthma and other respiratory system disorders
10/16/2003US20030194399 Preparation of deallergenized proteins and permuteins
10/16/2003US20030194398 Having serine protease inhibitory activity
10/16/2003US20030194396 Antisense oligonucleotide that hybridizes iwth and inhibits the expression of human pituitary tumor-transforming gene
10/16/2003US20030194393 Toxoplasma gondii proteins, nucleic acid molecules, and uses thereof
10/16/2003US20030194392 Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA
10/16/2003US20030194391 Vaccine
10/16/2003CA2513149A1 A human ribonucleotide reductase m2 subunit
10/16/2003CA2483769A1 Identification and characterization of an anthocyanin mutant (ant1) in tomato
10/16/2003CA2482145A1 Identification and validation of novel targets for agrochemicals
10/16/2003CA2482138A1 La1 - the genome of a lactobacillus strain
10/16/2003CA2481837A1 Production process for antibody composition
10/16/2003CA2481829A1 Anti-idiotype anti-cea antibody molecules and its use as cancer vaccine
10/16/2003CA2481764A1 Plants with improved morphogenesis and method of constructing the same
10/16/2003CA2481719A1 Modified cea nucleic acid and expression vectors
10/16/2003CA2481656A1 Cells in which activity of the protein involved in transportation of gdp-fucose is reduced or lost
10/16/2003CA2481481A1 Process for isolating nucleic acid with chaotrope agents and ammonium compounds
10/16/2003CA2481437A1 Motif-grafted hybrid polypeptides and uses thereof
10/16/2003CA2481318A1 Identification of virulence associated regions rd1 and rd5 leading to improve vaccine of m. bovis bcg and m. microti
10/16/2003CA2481300A1 Association of edg5 polymorphism v286a with type ii diabetes mellitus and venous thrombosis/pulmonary embolism and the use thereof
10/16/2003CA2481090A1 Novel pancortin-pablo protein interactions and methods of use thereof
10/16/2003CA2481039A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/16/2003CA2480802A1 A method for selecting cell lines to be used for nuclear transfer in mammalian species
10/16/2003CA2480786A1 Recombinant p. falciparum merozoite protein-142 vaccine
10/16/2003CA2480504A1 Method of designing synthetic nucleic acid sequences for optimal protein expression in a host cell
10/16/2003CA2480450A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/16/2003CA2480311A1 Oligomeric compounds for the modulation of hif-1alpha expression
10/16/2003CA2480084A1 Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis
10/16/2003CA2479927A1 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same
10/16/2003CA2479177A1 Phage display affinity and specificity filters and forward screen
10/16/2003CA2478983A1 Solid phase methods for polynucleotide production
10/16/2003CA2478939A1 Enhancer sequence of the 5-aminolevulinic acid synthase gene
10/16/2003CA2478930A1 Epitope constructs comprising antigen presenting cell targeting mechanisms
10/16/2003CA2478901A1 Methods of virus production
10/16/2003CA2477421A1 Novel promoter
10/16/2003CA2477298A1 Use of biomolecular targets in the treatment and visualization of brain tumors
10/16/2003CA2464144A1 Functionalized compositions for improved immobilization
10/15/2003EP1353180A2 Labelling and selection of molecules
10/15/2003EP1353179A1 Fluorescent analysis element with the use of metallic nanowell and process for producing the same
10/15/2003EP1352976A2 Method of spotting probe on solid support, probe array and method of manufacturing thereof, and method of detecting target substance and method of identifying structure of target substance using probe array
10/15/2003EP1352975A2 Selection of sites for targeting by zinc finger proteins and methods of designing zinc fingers proteins to binds to preselected sites
10/15/2003EP1352974A1 Oligonucleotide for detection of atypical mycobacteria mycobacterium avium and detection method
10/15/2003EP1352973A2 Automatic genotype determination
10/15/2003EP1352972A2 Methods of identifying a pharmaceutically active compound for the treatment of a condition caused by altered expression of the insulin receptor
10/15/2003EP1352971A2 DNA diagnostics based on mass spectrometry
10/15/2003EP1352966A2 Method for producing L-amino acid
10/15/2003EP1352963A1 Gene silencing
1 ... 2399 2400 2401 2402 2403 2404 2405 2406 2407 2408 2409 2410 2411 2412 2413 2414 2415 2416 2417 2418 2419 ... 4023